A carregar...
Neoadjuvant Chemotherapy or Endocrine Therapy for Invasive Ductal Carcinoma of the Breast With High Hormone Receptor Positivity and Human Epidermal Growth Factor Receptor 2 Negativity
IMPORTANCE: Although neoadjuvant endocrine therapy (NET) is an alternative to chemotherapy for strongly hormone receptor (HR)–positive and human epidermal growth factor receptor 2 (ERBB2)–negative breast cancer, evidence is currently lacking regarding the probable survival outcomes of NET in compari...
Na minha lista:
| Publicado no: | JAMA Netw Open |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Medical Association
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7955271/ https://ncbi.nlm.nih.gov/pubmed/33710293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2021.1785 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|